Examining your relationship with CROs

Today we welcome another regular contributor to our Industry Voices column. Stephanie Wells is the Corporate Senior Vice President, Marketing and Chief Marketing Officer at Charles River Laboratories, a U.S.-based CRO with more than 9,000 employees worldwide. Wells has over twenty-five years of healthcare business experience, and has previously worked at Prior Ortho-Clinical Diagnostics (a Johnson & Johnson company) and Bayer Diagnostics.

Wells' executive position at a leading CRO has given her insight into how biotech and pharmaceutical companies can maximize their relationships with CROs. This changing healthcare landscape, she says, is the driving force behind a collaborative evolution within the industry, transforming traditional pharma-CRO relationships. To get Well's advice, scroll down or click here to read her article on getting the most from your CRO. - Maureen

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.